STOCK TITAN

CanaQuest Medical Corp. - CANQF STOCK NEWS

Welcome to our dedicated page for CanaQuest Medical news (Ticker: CANQF), a resource for investors and traders seeking the latest updates and insights on CanaQuest Medical stock.

CanaQuest Med Corp (CANQF) is a cutting-edge company that specializes in developing health products and pharmaceuticals utilizing hemp, cannabis, and algae oils. They are commercializing a proprietary biosilo(r) algae cultivation system for high-volume, low-cost production of pure, contaminant-free algae biomass rich in omega-3 fatty acids. With ongoing research at two Canadian universities, they aim to combine the health benefits of omega-3s from algae oil and cannabis oil extracts to develop products focused on cancer and mental health pharmacotherapies.

Rhea-AI Summary

CanaQuest Medical Corp (OTC: CANQF) has announced strategic additions to its executive team to advance its drug candidate CQ-001 through clinical trials. Dr. Jordyn Stuart, with extensive experience in cannabinoid therapeutics, and Dr. Paul Dick, a veteran in pharmaceutical product development, have joined as Lead Scientific Advisor and Chairman of the Advisory Board, respectively.

Dr. Stuart's background includes the FDA-approved launch of Epidiolex at Greenwich Biosciences, while Dr. Dick brings over 30 years of experience in pharmaceutical and animal health industries.

Preclinical trials on rodents showed positive effects on anxiety and memory, and a preclinical epilepsy model demonstrated a 35% increase in potency for CQ-001 compared to isolated CBD. CanaQuest has also been named the Endocannabinoid Therapeutics Development Company of the Year 2024 by Global Health & Pharma, UK.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-100%
Tags
-
Rhea-AI Summary
The NHL Alumni Association (NHLAA), NEEKA Health Canada, and CanaQuest Medical Corp have formed a study partnership to investigate the efficacy of Mentanine® in reducing anxiety in former NHL players. NEEKA will lead the research on Mentanine®, a natural cannabidiol and essential fatty acid product, to evaluate its effectiveness in improving the quality of life. The study will be conducted by NEEKA's clinical research team led by Dr. Hunter Land, Chief Scientific Officer of NEEKA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.1%
Tags
partnership
-
Rhea-AI Summary
CanaQuest Medical Corp awarded European Cannabinoid Patent for Mentabinol®, a novel THC formulation to reduce cannabis-induced negative neuropsychiatric side-effects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
CanaQuest Medical Corp has been awarded the Best Global Medical Cannabinoid Development Company 2023 in the Healthcare and Pharmaceutical Awards by Global Health & Pharma.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-35%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is CanaQuest Med Corp's core focus?

CanaQuest is focused on developing unique health products and pharmaceuticals using hemp, cannabis, and algae oils.

What is the proprietary system CanaQuest is commercializing?

CanaQuest is commercializing a biosilo(r) algae cultivation system for high-volume, low-cost production of pure, contaminant-free algae biomass rich in omega-3 fatty acids.

What is the goal of the research collaboration with Canadian universities?

The collaboration aims to combine omega-3 fatty acids from algae oil with cannabis oil extracts to develop products targeting cancer and mental health pharmacotherapies.

What are some key areas of focus for CanaQuest's research?

CanaQuest's research is centered around the use of cannabis oil in cancer treatment and the development of novel pharmacotherapies for mental health.

What distinguishes CanaQuest in the health industry?

CanaQuest's innovative approach to product development using natural oils sets them apart in the health industry.

CanaQuest Medical Corp.

OTC:CANQF

CANQF Rankings

CANQF Stock Data

471.05k
9.28M
53.91%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Mississauga